Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lianxing Liu

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Virologica Sinica|April 12, 2013
Potent T cell responses induced by single DNA vaccine boosted with recombinant vaccinia vaccineLianxing Liu, Chao Qiu, Yang Huang, et al.
Journal of Immunological Methods|July 23, 2011
Transfection optimization for primary human CD8+ cellsLianxing Liu, Carl Johnson, Sue Fujimura, et al.
AIDS Research and Human Retroviruses|June 9, 2009
Deglycosylation or partial removal of HIV-1 CN54 gp140 V1/V2 domain enhances env-specific T cellsYanmin Wan, Lianxing Liu, Lan Wu, et al.
Vaccine|December 7, 2007
Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responsesXianggang Huang, Lianxing Liu, Li Ren, et al.
Vaccine|March 14, 2007
Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccinesYanmin Wan, Lan Wu, Lianxing Liu, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Immunogenicity comparison between codon optimized HIV-1 CRF BC_07 gp140 and gp145 vaccinesLianxing Liu, Yanmin Wan, Jianqing Xu, et al.
Vaccine|May 8, 2012
Broad HIV-1 neutralizing antibody response induced by heterologous gp140/gp145 DNA prime-vaccinia boost immunizationLianxing Liu, Yanling Hao, Zhenwu Luo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2013
Nevirapine inhibits the anti-HIV activity of CD8+ cellsLianxing Liu, Lin Wang, Liusheng Huang, et al.
Virus Research|February 26, 2008
Truncation of cytoplasmic tail of EIAV Env increases the pathogenic necrosisQinglai Meng, Shenwei Li, Lianxing Liu, et al.
Retrovirology|September 3, 2010
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccineLianxing Liu, Yanmin Wan, Lan Wu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Virologica Sinica|April 12, 2013
Potent T cell responses induced by single DNA vaccine boosted with recombinant vaccinia vaccineLianxing Liu, Chao Qiu, Yang Huang, et al.
Journal of Immunological Methods|July 23, 2011
Transfection optimization for primary human CD8+ cellsLianxing Liu, Carl Johnson, Sue Fujimura, et al.
AIDS Research and Human Retroviruses|June 9, 2009
Deglycosylation or partial removal of HIV-1 CN54 gp140 V1/V2 domain enhances env-specific T cellsYanmin Wan, Lianxing Liu, Lan Wu, et al.
Vaccine|December 7, 2007
Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responsesXianggang Huang, Lianxing Liu, Li Ren, et al.
Vaccine|March 14, 2007
Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccinesYanmin Wan, Lan Wu, Lianxing Liu, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Immunogenicity comparison between codon optimized HIV-1 CRF BC_07 gp140 and gp145 vaccinesLianxing Liu, Yanmin Wan, Jianqing Xu, et al.
Vaccine|May 8, 2012
Broad HIV-1 neutralizing antibody response induced by heterologous gp140/gp145 DNA prime-vaccinia boost immunizationLianxing Liu, Yanling Hao, Zhenwu Luo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2013
Nevirapine inhibits the anti-HIV activity of CD8+ cellsLianxing Liu, Lin Wang, Liusheng Huang, et al.
Virus Research|February 26, 2008
Truncation of cytoplasmic tail of EIAV Env increases the pathogenic necrosisQinglai Meng, Shenwei Li, Lianxing Liu, et al.
Retrovirology|September 3, 2010
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccineLianxing Liu, Yanmin Wan, Lan Wu, et al.
Pageof 2